Health Economics Pharmacoeconomics

Research Frontiers in Alzheimer''s Disease Biomarker Screening Economics

Economic evaluation of amyloid and tau biomarker screening for early intervention with disease-modifying medications in dementia.

All Health Economics & Pharmacoeconomics PhD categories